Funding
Open Access funding enabled and organized by Projekt DEAL. The JAKoMo trial was funded by Novartis, Germany. As the sponsor of this trial Novartis was involved in the design of the study. Collection, analysis, and interpretation of data and in writing the manuscript were done by investigators in collaboration to Novartis.